3-133756943-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001063.4(TF):​c.804T>C​(p.His268His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,614,086 control chromosomes in the GnomAD database, including 1,369 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.054 ( 714 hom., cov: 32)
Exomes 𝑓: 0.0056 ( 655 hom. )

Consequence

TF
NM_001063.4 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.54

Publications

5 publications found
Variant links:
Genes affected
TF (HGNC:11740): (transferrin) This gene encodes a glycoprotein with an approximate molecular weight of 76.5 kDa. It is thought to have been created as a result of an ancient gene duplication event that led to generation of homologous C and N-terminal domains each of which binds one ion of ferric iron. The function of this protein is to transport iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. This protein may also have a physiologic role as granulocyte/pollen-binding protein (GPBP) involved in the removal of certain organic matter and allergens from serum. [provided by RefSeq, Sep 2009]
TF Gene-Disease associations (from GenCC):
  • atransferrinemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 3-133756943-T-C is Benign according to our data. Variant chr3-133756943-T-C is described in ClinVar as Benign. ClinVar VariationId is 343440.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.54 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.183 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TFNM_001063.4 linkc.804T>C p.His268His synonymous_variant Exon 7 of 17 ENST00000402696.9 NP_001054.2 P02787Q06AH7A0PJA6
TFNM_001354703.2 linkc.672T>C p.His224His synonymous_variant Exon 13 of 23 NP_001341632.2
TFNM_001354704.2 linkc.423T>C p.His141His synonymous_variant Exon 6 of 16 NP_001341633.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TFENST00000402696.9 linkc.804T>C p.His268His synonymous_variant Exon 7 of 17 1 NM_001063.4 ENSP00000385834.3 P02787
TFENST00000485977.1 linkn.169T>C non_coding_transcript_exon_variant Exon 3 of 5 3 ENSP00000418716.1 F8WC57
TFENST00000482271.5 linkc.*20T>C downstream_gene_variant 4 ENSP00000419338.1 C9JVG0

Frequencies

GnomAD3 genomes
AF:
0.0538
AC:
8191
AN:
152130
Hom.:
712
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.187
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0217
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000735
Gnomad OTH
AF:
0.0359
GnomAD2 exomes
AF:
0.0142
AC:
3566
AN:
251434
AF XY:
0.0102
show subpopulations
Gnomad AFR exome
AF:
0.192
Gnomad AMR exome
AF:
0.00968
Gnomad ASJ exome
AF:
0.000496
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000484
Gnomad OTH exome
AF:
0.00619
GnomAD4 exome
AF:
0.00558
AC:
8164
AN:
1461838
Hom.:
655
Cov.:
33
AF XY:
0.00483
AC XY:
3509
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.193
AC:
6458
AN:
33480
American (AMR)
AF:
0.0111
AC:
496
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.000421
AC:
11
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000325
AC:
28
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00884
AC:
51
AN:
5768
European-Non Finnish (NFE)
AF:
0.000335
AC:
373
AN:
1111970
Other (OTH)
AF:
0.0124
AC:
747
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
439
878
1318
1757
2196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
196
392
588
784
980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0539
AC:
8203
AN:
152248
Hom.:
714
Cov.:
32
AF XY:
0.0523
AC XY:
3897
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.186
AC:
7740
AN:
41522
American (AMR)
AF:
0.0216
AC:
331
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000735
AC:
50
AN:
68018
Other (OTH)
AF:
0.0355
AC:
75
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
325
650
974
1299
1624
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0277
Hom.:
331
Bravo
AF:
0.0611
Asia WGS
AF:
0.0100
AC:
37
AN:
3478
EpiCase
AF:
0.000654
EpiControl
AF:
0.000474

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Atransferrinemia Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.21
DANN
Benign
0.55
PhyloP100
-1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8177232; hg19: chr3-133475787; API